Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Jazz Pharmaceuticals plc (JAZZ)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2024 Q1 | 4,187 | 0.01 | Buy | 0.01 | $120.42 | $504,199 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q3 | 10,120 | 0.01 | Reduce 60.86% | 0.02 | $130.24 | $1,318,000 | SEC |
| 2021 Q2 | 25,858 | 0.04 | Add 39.55% | 0.01 | $177.62 | $4,593,000 | SEC |
| 2021 Q1 | 18,529 | 0.03 | Add 104.76% | 0.02 | $164.39 | $3,046,000 | SEC |
| 2020 Q4 | 9,049 | 0.02 | Buy | 0.02 | $165.10 | $1,494,000 | SEC |
| 2019 Q2 | 0 | 0.00 | Sell 100.00% | 0.08 | SEC | ||
| 2019 Q1 | 39,040 | 0.08 | Add 4.25% | <0.01 | $142.96 | $5,581,000 | SEC |
| 2018 Q4 | 37,450 | 0.07 | Add 1.55% | <0.01 | $123.95 | $4,642,000 | SEC |
| 2018 Q3 | 36,880 | 0.08 | Reduce 12.00% | 0.01 | $168.14 | $6,201,000 | SEC |
| 2018 Q2 | 41,910 | 0.09 | Reduce 32.79% | 0.04 | $172.30 | $7,221,000 | SEC |
| 2018 Q1 | 62,360 | 0.13 | Add 43.22% | 0.04 | $150.99 | $9,416,000 | SEC |
| 2017 Q4 | 43,540 | 0.08 | Add 99.91% | 0.04 | $134.66 | $5,863,000 | SEC |
| 2017 Q3 | 21,780 | 0.04 | Add 38.81% | 0.01 | $146.24 | $3,185,000 | SEC |
| 2017 Q2 | 15,690 | 0.03 | Add 54.13% | 0.01 | $155.51 | $2,440,000 | SEC |
| 2017 Q1 | 10,180 | 0.02 | Reduce 16.83% | <0.01 | $145.09 | $1,477,000 | SEC |
| 2016 Q4 | 12,240 | 0.02 | Add 26.06% | <0.01 | $109.07 | $1,335,000 | SEC |
| 2016 Q3 | 9,710 | 0.01 | Add 18.27% | <0.01 | $121.52 | $1,180,000 | SEC |
| 2016 Q2 | 8,210 | 0.02 | Reduce 9.48% | <0.01 | $141.29 | $1,160,000 | SEC |
| 2016 Q1 | 9,070 | 0.02 | Buy | 0.02 | $130.54 | $1,184,000 | SEC |